Carl Zeiss Meditec (DE:AFX)
XETRA:AFX
Want to see DE:AFX full AI Analyst Report?
Total Valuation
Carl Zeiss Meditec has a market cap or net worth of €2.44B. The enterprise value is €2.80B.
Market Cap€2.44B
Enterprise Value€2.80B
Share Statistics
Carl Zeiss Meditec has 89,440,570 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding89,440,570
Owned by Insiders―
Owned by Institutions0.01%
Financial Efficiency
Carl Zeiss Meditec’s return on equity (ROE) is 0.07 and return on invested capital (ROIC) is 5.50%.
Return on Equity (ROE)0.07
Return on Assets (ROA)0.04
Return on Invested Capital (ROIC)5.50%
Return on Capital Employed (ROCE)0.08
Revenue Per Employee385.14K
Profits Per Employee24.61K
Employee Count5,784
Asset Turnover0.64
Inventory Turnover2.12
Valuation Ratios
The current PE Ratio of Carl Zeiss Meditec is 20.1. Carl Zeiss Meditec’s PEG ratio is -1.32.
PE Ratio20.1
PS Ratio1.66
PB Ratio1.74
Price to Fair Value1.74
Price to FCF21.65
Price to Operating Cash Flow6.53
PEG Ratio-1.32
Income Statement
In the last 12 months, Carl Zeiss Meditec had revenue of 2.23B and earned 141.21M in profits. Earnings per share was 1.61.
Revenue2.23B
Gross Profit1.18B
Operating Income223.32M
Pretax Income193.89M
Net Income141.21M
EBITDA346.89M
Earnings Per Share (EPS)1.61
Cash Flow
In the last 12 months, operating cash flow was 357.46M and capital expenditures -27.76M, giving a free cash flow of 370.30M billion.
Operating Cash Flow357.46M
Free Cash Flow370.30M
Free Cash Flow per Share4.14
Dividends & Yields
Carl Zeiss Meditec pays an annual dividend of €0.55, resulting in a dividend yield of 1.5%
Dividend Per Share€0.55
Dividend Yield1.5%
Payout Ratio32.52%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.44
52-Week Price Change-51.03%
50-Day Moving Average26.21
200-Day Moving Average33.17
Relative Strength Index (RSI)58.13
Average Volume (3m)154.89K
Important Dates
Carl Zeiss Meditec upcoming earnings date is Aug 6, 2026, TBA (Confirmed).
Last Earnings DateMay 12, 2026
Next Earnings DateAug 6, 2026
Ex-Dividend Date―
Financial Position
Carl Zeiss Meditec as a current ratio of 2.35, with Debt / Equity ratio of 29.43%
Current Ratio2.35
Quick Ratio1.44
Debt to Market Cap0.14
Net Debt to EBITDA1.67
Interest Coverage Ratio8.39
Taxes
In the past 12 months, Carl Zeiss Meditec has paid 51.55M in taxes.
Income Tax51.55M
Effective Tax Rate0.27
Enterprise Valuation
Carl Zeiss Meditec EV to EBITDA ratio is 12.31, with an EV/FCF ratio of 25.05.
EV to Sales1.92
EV to EBITDA12.31
EV to Free Cash Flow25.05
EV to Operating Cash Flow20.35
Balance Sheet
Carl Zeiss Meditec has €23.90M in cash and marketable securities with €617.55M in debt, giving a net cash position of -€593.66M billion.
Cash & Marketable Securities€23.90M
Total Debt€617.55M
Net Cash-€593.66M
Net Cash Per Share-€6.64
Tangible Book Value Per Share€5.66
Margins
Gross margin is 50.81%, with operating margin of 10.02%, and net profit margin of 6.34%.
Gross Margin50.81%
Operating Margin10.02%
Pretax Margin8.70%
Net Profit Margin6.34%
EBITDA Margin15.57%
EBIT Margin9.90%
Analyst Forecast
The average price target for Carl Zeiss Meditec is €27.65, which is 11.43% higher than the current price. The consensus rating is Hold
Price Target€27.65
Price Target Upside-0.90% Downside
Analyst ConsensusHold
Analyst Count8
Revenue Growth Forecast-0.06%
EPS Growth Forecast-38.81%